QUEEN ELIZABETH II CONFERENCE CENTRE
SCIENTIFIC PROGRAMME
COMPARISON OF BTS AND AMERICAN TREATMENT REGIMENS FOR ACUTE ASTHMA PRESENTING TO AN ACCIDENT AND EMERGENCY DEPT S1
THE EFFICACY OF REGULAR VERSUS AS-REQUIRED NEBULISED SALBUTAMOL IN PATIENTS ADMITTED TO HOSPITAL WITH ACUTE ASTHMA
COMPARISON OF A LOWER FIXED DOSE OF INHALED FLUTICASONE PROPIONATE (FP) WITH A HIGH DOSE STEPDOWN REGIMEN OF FP IN THE PREVENTION OF RE-EXACERBATIONS AFTER AN ACUTE SEVERE ATTACK OF ASTHMA REQUIRING ORAL CORTICOSTEROID THERAPY S3
INTERACTION BETWEEN INHALED BETA-AGONISTS AND INHALED CORTICOSTEROIDS IN THE CONTROL OF ASTHMA S4
BONE DENSITOMETRY SCANS IN CHEST CLINIC PATIENTS RECEIVING ORAL CORTICOSTEROIDS S5
INDOOR ENVIRONMENT CHANGES AND RESPIRATORY HEALTH S6
INDOOR ALLERGEN EXPOSURES ARE NOT RELATED TO CURRENT ASTHMA IN ATOPIC ADULTS S7
MOULD ALLERGY IS COMMONER THAN HOUSE DUST MITE ALLERGY IN SALFORD PATIENTS WITH MULTIPLE HOSPITAL ADMISSIONS FOR ASTHMA
THE EFFECT OF HIGH EFFICIENCY PARTICULATE AIR CLEANER ON AIRBORNE CAT ALLERGEN S9
MEASURES FOR ACHIEVING LOW ALLERGEN ENVIRONMENT IN PREGNANCY AND IN EARLY LIFE S10
EFFECT OF MITE ALLERGEN AVOIDANCE ON Der p 1 LEVELS IN SETTLING DUST IN UK HOMES S11
A DOUBLE BLIND PLACEBO CONTROLLED TRIAL OF PULMONARY AND NASAL ADMINISTRATION OF LIPOSOME-MEDIATED CFTR GENE TRANSFER IN CF SUBJECTS. S12
A COMPARISON OF THE CLINICAL OUTCOME OF SYMPTOMATIC AND ELECTIVE REGULAR INTRAVENOUS ANTIBIOTICS IN THE TREATMENT OF CYSTIC FIBROSIS. S13
METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS
INCIDENCE AND TREATMENT OF METHICILLIN RESISTANT STAPH AUREUS (MRSA) POSITIVE SPUTUM CULTURES IN AN ADULT CYSTIC FIBROSIS (CF) CLINIC S15
TAUROLIDINE IN ADULT CYSTIC FIBROSIS PATIENTS COLONISED WITH EPIDEMIC BURKHOLDERIA CEPACIA S16
EXERCISE LIMITATION AND SYMPTOMS AT PEAK CYCLE ERGOMETRY IN ADULTS WITH CYSTIC FIBROSIS S17
A PROSPECTIVE, RANDOMISED, DOUBLE-BLIND, PLACEBO CONTROLLED STUDY OF ORAL CORTICOSTEROIDS IN PATIENTS ADMITTED WITH NORMOCAPNIC ACUTE EXACERBATIONS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) S18
COMBINATION BRONCHODILATORS IN THE ASSESSMENT OF SHORT-TERM REVERSIBILITY IN COPD S19
THE EFFECT OF EXERCISE AND HYPOXAEMIA ON MYOCARDIAL REPOLARISATION IN SEVERE CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) S20
COMPARISON OF PULSED DOSE OXYGEN DELIVERY AND CONTINUOUS OXYGEN DELIVERY DURING EXERCISE IN PATIENTS WITH COPD S21
EFFECT OF COLD EXPOSURE ON LUNG FUNCTION IN COPD PATIENTS WITH EXACERBATION. S22
THE NATURE OF EXACERBATIONS OF COPD S23
AIR POLLUTION AND RESPIRATORY HEAL^TH IN SCHOOL CHILDREN IN EAST LONDON S24
LOW ASTHMA PREVALENCE IN RURAL POPULATIONS OF DEVELOPING COUNTRIES - TEMPORAL RELATIONSHIP BETWEEN URBANIZATION AND DEVELOPMENT OF ASTHMA. S25
DAMP HOUSING, SENSITISATION TO HOUSE DUST MITE AND RESPIRATORY SYMPTOMS S26
GEOGRAPHIC VARIATIONS IN THE PREVALENCE OF ASTHMA SYMPTOMS AND ITS ASSOCIATION WITH POVERTY S27
SEASONAL DISTRIBUTION OF EPISODES OF ACUTE SEVERE ASTHMA IN ADULTS S28
MICROBIAL EXPOSURE IN CHILDHOOD AND SUBSEQUENT ATOPY
CONTROLLED TRIAL OF HYPNOTHERAPY FOR WEIGHT LOSS IN PATIENTS WITH OBSTRUCTIVE SLEEP APNOEA (OSA) S30
PROSPECTIVE AUDIT OF THE INVESTIGATION AND TREATMENT OF SNORING AND OBSTRUCTIVE SLEEP APNOEA (OSA) IN THE NOTTINGHAM HEALTH DISTRICT S31
AUDIT OF SLEEP APNOEA IN HEARTLANDS HOSPITAL S32
PROVISION OF CPAP MACHINES IN AVON IN THE FINANCIAL YEAR 1996-1997 S33
PATTERNS OF CONTINUOUS POSITIVE AIRWAYS PRESSURE (CPAP) USE AT THE SCOTTISH NATIONAL SLEEP CENTRE S34
CAN AUTONOMIC AROUSALS AND NEURAL NET EEG ANALYSIS PREDICT DAYTIME SLEEPINESS AND ITS RESPONSE TO nCPAP IN OSA? S35
THE RELATIONSHIP BETWEEN SLEEP FRAGMENTATION, DAYTIME SLEEPINESS AND QUALITY OF LIFE IN OSA AND PREDICTORS OF IMPROVEMENT IN QUALITY OF LIFE ON NCPAP S36
QUALITY OF LIFE IN END-STAGE CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) AND LUNG CANCER
A RANDOMISED CONTROLLED TRIAL OF PULMONARY REHABILITATION (PR) IN A DISTRICT GENERAL HOSPITAL S38
DOES PULMONARY REHABILITATION PRODUCE A LASTING BENEFIT IN PATIENTS WITH COPD? S39
PROLONGED EFFECTS OF PULMONARY REHABILITATION IN PATIENTS WITH COPD S40
A RANDOMISED TRIAL OF HOSPITAL V HOME REHABILITATION IN SEVERE CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) S41
COMPARISON OF OUTCOME OF PULMONARY REHABILITATION IN OBSTRUCTIVE LUNG DISEASE, INTERSTITIAL LUNG DISEASE AND CHEST WALL DISEASE. S42
AUTONOMIC DYSFUNCTION IN PATIENTS WITH CHEST WALL DEFORMITY
AUTONOMIC NEUROPATHY AND LTOT IN PATIENTS WITH COPD. S44
THE PREVALENCE OF NOCTURNAL DESATURATION IN CHRONIC HEART FAILURE S45
THE EFFECT OF NOCTURNAL SUPPLEMENTAL OXYGEN ON SLEEP QUALITY AND DAYTIME COGNITIVE FUNCTION IN CHRONIC HEART FAILURE S46
PREDICTORS OF OVERNIGHT BLOOD PRESSURE (BP) CHANGES IN NORMAL SUBJECTS S47
PNEUMONIA DEATHS IN YOUNG ADULTS IN ENGLAND AND WALES - INCIDENCE, PRE-EXISTING DISEASE AND DEATH CERTIFICATES S48
Soluble and Surface Adhesion Molecules in Community Acquired Pneumonia(CAP) S49
Systemic IL-6 and IL-10 levels in Community Aquired Pneumonia S50
A MODEL OF HUMAN ALVEOLAR MACROPHAGE INTERACTIONS WITH STREPTOCOCCUS PNEUMONIAE S51
BRONCHIAL INFLAMMATION IN PATIENTS COLONISED WITH HAEMOPHILUS PARAINFLUENZAE AND NON-TYPEABLE HAEMOPHILUS INFLUENZAE S52
DOWN REGULATION OF HUMAN DEFENSIN-1 (hBD-1) IN RESPIRATORY SYNCYTIAL VIRUS INFECTION S53
COMPARISON OF CELL VIABILITY AND COUNTS IN SPONTANEOUS AND INDUCED SPUTUM IN PATIENTS WITH COPD S54
BETWEEN OBSERVER REPEATABILITY OF SPUTUM DIFFERENTIAL CELL COUNTS. INFLUENCE OF CELL VIABILITY AND SQUAMOUS CELL CONTAMINATION S55
INDUCED SPUTUM TO ASSESS AIRWAY INFLAMMATION IN ASTHMA. VALIDITY AND REPEATABILITY OF SPUTUM DIFFERENTIAL CELL COUNTS S56
EFFECTS OF INHALED LIPOPOLYSACHARIDE ON NEUTROPHIL NUMBERS IN INDUCED SPUTUM IN NORMAL AND ASTHMATIC SUBJECTS S57
SAFETY OF SPUTUM INDUCTION IN PATIENTS WITH COPD S58
SUCCESS RATE AND SAFETY OF SPUTUM INDUCTION USING HYPERTONIC SALINE S59
A NATIONWIDE PROGRAMME FOR DETECTION OF a1-ANTITRYPSIN DEFICIENCY IN ITALY S60
MONITORING THE PROGRESS OF EMPHYSEMA IN PATIENTS WITH SEVERE ALPHA1-ANTITRYPSIN DEFICIENCY BY COMPUTER TOMOGRAPHY (CT) S61
POLYMERISATION OF THE I VARIANT OF alpha1-ANTITRYPSIN RESULTS IN PLASMA DEFICIENCY AND LIVER CIRRHOSIS S62
QUANTUM PROTEOLYSIS BY NEUTROPHILS (PMN)
BRONCHIAL INFLAMMATION DURING AN ACUTE EXACERBATION IN PATIENTS HOMOZYGOUS FOR ALPHA-1-ANTITRYPSIN DEFICIENCY S64
NEUTROPHIL COLLAGENASE (MMP-8) DOES NOT EXERT SERPINASE ACTIVITY AGAINST SECRETORY LEUCOCYTE PROTEINASE INHIBITOR OR ELAFIN S65
HOSPITAL MANAGEMENT OF ASTHMA, 1990-7 S66
ONE WEEK REVIEW AFTER ADMISSION WITH ACUTE SEVERE ASTHMA
IMPACT OF ASTHMA EDUCATION ON QUALITY OF LIFE IN WHITE EUROPEAN AND INDIAN SUBCONTINENT GROUPS S68
NON ACUTE ASTHMA REVIEW IN GENERAL PRACTICE
A GENERAL PRACTICE BASED COMMUNITY INTERVENTION TRIAL ON THE MANAGEMENT OF ASTHMA S70
EFFECT OF THE ASTHMA MANAGMENT GUIDELINES ON RECRUITMENT TO A RCT OF EARLY INTRODUCTION OF INHALED STEROIDS IN ASTHMA S71
DOES NOCTURNAL OXYGEN DESATURATION PREDICT SURVIVAL IN CHILDHOOD ONSET MUSCULAR DYSTROPHY (MD) S72
PREDICTORS OF HYPERCAPNIC RESPIRATORY FAILURE IN PATIENTS WITH MOTOR NEURONE DISEASE S73
DIAPHRAGM STRENGTH SOON AFTER THE DIAGNOSIS OF MOTOR NEURONE DISEASE S74
DIAPHRAGM AND LIMB MUSCLE STRENGTH IN THE CRITICAL CARE UNIT S75
ASSESSMENT OF NEONATAL DIAPHRAGM FUNCTION BY MAGNETIC STIMULATION OF THE PHRENIC NERVES S76
SURVIVAL TO DISCHARGE FROM HOSPITAL IN A PROGRESSIVE CARE PROGRAMME (PCP) FOR PATIENTS FAILING TO WEAN FROM VENTILATION ON ICU S77
INCREASED LEVELS OF ENDOTHELIN-1 AND DIFFERENTIAL ENDOTHELIN TYPEA ANDB RECEPTOR EXPRESSION IN SCLERODERMA-ASSOCIATED FIBROTIC LUNG DISEASE S78
CONNECTIVE TISSUE GROWTH FACTOR IN SCLERODERMA-ASSOCIATED FIBROTIC LUNG DISEASE S79
DOES VASCULAR PERMEABILITY FACTOR PLAY A ROLE IN INTERSTITIAL LUNG DISEASE? S80
EXPRESSION OF FAS AND ITS LIGAND BY ALVEOLAR T-LYMPHOCYTES IN PULMONARY SARCOIDOSIS S81
WHAT'S THE MEANING OF THE IMPAIRED PHAGOCYTOSIS AND INTRACELLULAR KILLING IN SOME PULMONARY INTERSTITIOPATHIES? S82
FIBRONECTIN GENE POLYMORPHISMS AND SCLERODERMA LUNG FIBROSIS S83
GENETIC PREDISPOSITION TO SARCOIDOSIS
A RANDOMISED CONTROLLED TRIAL OF INSPIRATORY MUSCLE TRAINING IN STABLE CHRONIC HEART FAILURE S85
CHANGES IN COUGH FREQUENCY AND COUGH RECEPTOR SENSITIVITY AT SIMULATED ALTITUDE ARE NOT DUE TO CHANGES IN TEMPERATURE OR HUMIDITY S86
CHANGES IN LUNG FUNCTION ON ASCENT TO ALTITUDE S87
EFFECT OF ARM POSITION ON THE ABILITY TO WITHSTAND RESTRICTION OF VITAL CAPACITY BY AN EXTERNAL COMPRESSIVE FORCE S88
CO2 sensitivity in Idiopathic Hyperventilators. S89
The Reproducibility of Hypocapnia On Exercise Over Time in Idiopathic Hyperventilation Syndrome. S90
A SURVEY OF UK CHILDREN RECEIVING LONG-TERM VENTILATORY SUPPORT AT HOME S91
PARADOXICAL AIRWAY RESPONSIVENESS IN CHILDREN WITH PRIMARY CILIARY DYSKINESIA
PREDICTION OF PERSISTENT WHEEZE IN INFANTS S93
DOES DIMINISHED AIRWAY FUNCTION AT BIRTH PERSIST TO ONE YEAR OF AGE? S94
MATERNAL SMOKING AND INFANT HEALTH
DEVELOPMENTAL CHANGES IN THE ALVEOLAR MACROPHAGE DIFFERENTIAL AND IMMUNE RECEPTOR EXPRESSION IN NORMAL CHILDREN S96
PREVALENCE OF ACIDOSIS IN PATIENTS ADMITTED TO HOSPITAL WITH AN EXACERBATION OF CORD - IMPLICATIONS FOR NON-INVASIVE VENTILATION S97
A U.K. SURVEY OF THE PRACTICE OF NON-INVASIVE VENTILATION(NIPPV) IN ACUTE EXACERBATIONS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE S98
IMPACT OF NON-INVASIVE VENTILATION ON NURSING WORKLOAD-YORKSHIRE NON-INVASIVE VENTILATION TRIAL S99
AUDIT OF ANTIBIOTIC USE IN ACUTE EXACERBATIONS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE S100
ANTIBIOTIC SENSITIVITY OF BACTERIAL ISOLATES RECOVERED FROM HOSPITAL-BASED AND COMMUNITY-BASED PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE S101
MONITORING AND REPORTING OF COPD EXACERBATIONS IN THE COMMUNITY S102
SURVIVAL IN SMALL CELL LUNG CANCER TREATED BY CHEMOTHERAPY ALONE USING AN INEXPENSIVE FOUR DRUG COMBINATION S103
A.N.I.T.A. (ADJUVANT NAVELBINE INTERNATIONAL TRIALIST ASSOCIATION) A POSSIBLE SOLUTION TO THE UNRESOVED ISSUES IN ADJUVANT THERAPY FOR RESECTABLE NON-SMALL CELL LUNG CANCER (NSCLC) S104
SIX YEAR FOLLOW UP OF THE EUROPEAN MULTICENTRE RANDOMISED STUDY COMPARING NAVELBINE (NVB) ALONE VS NVB + CISPLATIN (CDDP) VS VINDESINE (VDS) + CDDP IN 612 PATIENTS (PTS) WITH ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC) S105
CHEMOTHERAPY IN NON-SMALL LUNG CANCER (NSCLC)
CANCER GENE THERAPY WITH A HEAT SHOCK PROTEIN GENE S107
SYSTEMIC OXIDATIVE STRESS IN PATIENTS WITH SMALL CELL LUNG CANCER S108
A STUDY OF A NEW CACHECTIC FACTOR IN A GROUP OF PATIENTS WITH EARLY LUNG CANCER S109
COMPARISON OF TWO NEW METHODS FOR THE MEASUREMENT OF LUNG VOLUMES WITH TWO GOLD STANDARD METHODS. S110
Use of End-Tidal CO2 as a Non-Invasive Estimate of Arterial PCO (2) S111
EXPIRED AIRFLOW PATTERNS IN OBSTRUCTED AIRWAYS S112
INSPIRATORY MUSCLE PERFORMANCE USING NEGATIVE PRESSURE INSPIRATORY LOADING S113
A SURVEY OF LUNG FUNCTION SERVICES OFFERED BY HOSPITALS IN THE UNITED KINGDOM S114
ABILITY OF SUBJECTS WITH RESPIRATORY DISEASES TO ACTIVATE THE LION INTOXILYZER 6000UK S115
TISSUE DISTRIBUTION OF CONSTITUTIVE AND INDUCIBLE HAEM OXYGENASE mRNA IN NORMAL AND LIPOPOLYSACCHARIDE (LPS) TREATED RATS S116
INFLUENCE OF HYPOXIA IN AUGMENTING IL-8 GENERATION FROM HUMAN MONOCYTES AND MACROPHAGES - POTENTIAL ROLE IN THE ACUTE RESPIRATORY DISTRESS SYNDROME. S117
DIFFERENTIAL EFFECTS OF INFLAMMATORY MEDIATORS ON PMN DEFORMABILITY AND ADHESION S118
TIME DEPENDENT EFFECTS OF L-NAME ON PULMONARY MACROMOLECULAR TRANSPORT IN ENDOTOXAEMIA S119
ULTRAFINE PARTICLES, LUNG INFLAMMATION AND OXIDANT STRESS S120
HYDROXYL RADICAL GENERATION OF RESPIRABLE INDUSTRIAL FIBRES. S121
THE LUNG CANCER RISK OF LONG TERM EX-SMOKERS IS MUCH LESS THAN THAT OF SMOKERS BUT MUCH HIGHER THAN THAT OF NON-SMOKERS P1
DELAYS IN THE MANAGEMENT OF LUNG CANCER - MOSTLY THE PATIENTS FAULT? P2
OUTCOME OF PATIENTS REFERRED BY GENERAL PRACTITIONERS TO A HOSPITAL RADIOLOGY DEPARTMENT FOR A CHEST RADIOGRAPH P3
AUDIT OF THE TIMELY MANAGEMENT OF PATIENTS WITH LUNG CANCER P4
THE EFFECT OF A DAILY 'DROP IN' CLINIC UPON DELAYS IN THE DIAGNOSIS AND MANAGEMENT OF LUNG CANCER P5
THE HISTOLOGICAL CONFIRMATION RATE OF LUNG CANCER IN SALFORD IN 1994 P6
A COMPARISON OF THE USE OF SPUTUM CYTOLOGY BY RESPIRATORY PHYSICIANS AND OTHER CLINICIANS P7
INFORMATION PROVISION AND PATIENTS' PERCEPTIONS IN LIFE-THREATENING RESPIRATORY DISEASE P8
PALLIATIVE CARE NEEDS OF PATIENTS WITH LUNG CANCER FOLLOWING THE BREAKING OF BAD NEWS IN AN OUTPATIENT CLINIC P9
PATIENT HELD RECORDS IN LUNG CANCER. A PILOT STUDY P10
Molecular Epidemiology of Tuberculosis in Inner London P11
Case-Control study of Lifestyle Risk Factors for Tuberculosis in Liverpool, UK P12
THE INFLUENCE OF AGE AND GENDER ON THE INCIDENCE OF DRUG RESISTANCE IN TUBERCULOSIS P13
TUBERCULOSIS IN HEALTHCARE WORKERS. A SURVEY OF CASES IN ENGLAND AND WALES P14
CONTACT TRACING SMEAR NEGATIVE AND NON-PULMONARY TUBERCULOSIS IN A HIGH-INCIDENCE AREA P15
A REAUDIT OF TUBERCULOSIS CONTACT TRACING IN SOUTH GLAMORGAN
Interpreting Tuberculin skin tests
IS NEW IMMIGRANT SCREENING FOR TUBERCULOSIS STILL WORTHWHILE? P18
Audit of tuberculosis notifications in Liverpool, UK P19
AUDIT OF TUBERCULOSIS NOTIFICATIONS P20
WHAT ARE THE EXPECTATIONS OF PATIENTS WITH TB WHEN VISITED AT HOME BY A SPECIALIST TB NURSE? P21
DEVELOPMENT OF A STANDARDISED MEASURE OF ACTIVITY OF DAILY LIVING IN PATIENTS WITH COPD
EFFECT OF EXACERBATION ON QUALITY OF LIFE IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE P23
EFFECTS OF A 12-WEEK SUPERVISED OUTPATIENT REHABILITATION PROGRAMME ON PHYSICAL PERFORMANCE IN PATIENTS WITH COPD IN THE NORTH EAST OF ENGLAND P24
BENEFITS OF A 12-WEEK OUTPATIENT REHABILITATION PROGRAMME ARE INDEPENDENT OF THE DEGREE OF LUNG DYSFUNCTION IN PATIENTS WITH COPD P25
PREDICTING MAXIMAL VENTILATION AND DYSPNOEA DURING CYCLE EXERCISE IN COPD PATIENTS P26
DOES PULMONARY REHABILITATION CHANGE EXERCISE BEHAVIOUR? P27
The Hippy Ventilator
PNEUMONIA BEFORE TWO YEARS OF AGE AND ADULT LUNG FUNCTION P29
RISK FACTORS FOR BRONCHIAL RESPONSIVENESS IN YOUNG ADULTS P30
ASPECTS OF ATOPY AMONG ASTHMATIC PATIENTS PRESENTING TO A HOSPITAL IN URBAN ZIMBABWE P31
Parental collection of specimens to show mite allergen exposure P32
Title
INACTIVATION OF DER P1 DEMONSTRATED BY SKIN - PRICK TESTING P34
ALLERGEN AVOIDANCE WITH DOG IN SITU
GEOGRAPHICAL VARIATION IN THE PREVALENCE OF ASTHMA SYMPTOMS IN NEW ZEALAND P36
CHRONIC BRONCHITIS, SHORTNESS OF BREATH AND AIRWAYS OBSTRUCTION BY OCCUPATION IN NEW ZEALAND P37
THE ASSOCIATION OF RESPIRATORY SYMPTOMS AND LUNG FUNCTION WITH THE USE OF GAS FOR COOKING; RESULTS FROM THE EUROPEAN COMMUNITY RESPIRATORY HEALTH SURVEY P38
A SYSTEM FOR THE GENERATION AND HEAD-ONLY DELIVERY OF SUBMICRONIC PARTICLES FOR THE STUDY OF THE HEALTH EFFECTS OF PARTICULATE AIR POLLUTION P39
SHOULD WE ADVISE PARENTS OF ASTHMATIC CHILDREN TO STOP SMOKING TO PROTECT THEIR CHILD'S HEALTH? P40
URINARY COTININE CONCENTRATIONS, REPORTED HOUSEHOLD SMOKING AND RESPIRATORY SYMPTOMS IN INNER CITY PRIMARY SCHOOL CHILDREN P41
CLINICAL OUTCOME AFTER ACQUISITION OF BURKHOLDERIA CEPACIA P42
LUNG FUNCTION AND BURKHOLDERIA CEPACIA COLONISATION
LONG TERM AZITHROMYCIN IMPROVES LUNG FUNCTION IN CHILDREN WITH CYSTIC FIBROSIS P44
FOUR YEARS EXPERIENCE OF INTRAVENOUS (IV) COLOMYCIN IN AN ADULT CYSTIC FIBROSIS UNIT P45
ARE REPEAT AMINOGLYCOSIDE LEVELS IN ADULT CYSTIC FIBROSIS PATIENTS NECESSARY? P46
PROVIDING RECOMBINANT DNASE ACCORDING TO LOCAL GUIDELINES IN A REGIONAL CYSTIC FIBROSIS UNIT P47
THE EFFECT OF POSTURE AND PHYSIOTHERAPY ON REFLUX IN ADULT CYSTIC FIBROSIS PATIENTS P48
EFFECT OF HYPERTONIC SALINE, ISOTONIC SALINE AND WATER CHALLENGES ON THE AIRWAYS OF CYSTIC FIBROSIS PATIENTS P49
INDUCTION OF SPUTUM IN CYSTIC FIBROSIS BY INHALED HYPERTONIC SALINE P50
FRACTURE PREVALENCE IN PATIENTS WITH CYSTIC FIBROSIS (CF). P51
THE PREVALENCE OF OSTEOPOROSIS IN ADULTS WITH CYSTIC FIBROSIS P52
SEVERE OSTEOPOROSIS IN CYSTIC FIBROSIS PATIENTS POST TRANSPLANTATION P53
A CONFIDENTIAL STUDY OF AWARENESS OF INFERTILITY AND SEXUAL MATTERS IN MALES WITH CYSTIC FIBROSIS P54
TOTAL ENERGY EXPENDITURE IN STABLE PATIENTS WITH CYSTIC FIBROSIS P55
SEX DIFFERENCES IN WEIGHT PERCEPTION IN CYSTIC FIBROSIS ADULTS IN THE UNITED KINGDOM P56
VALIDITY OF A VISUAL NUMERICAL GENERAL QUALITY OF LIFE SCALE AND CHEST SCALE IN ADULTS WITH CYSTIC FIBROSIS P57
RECRUITMENT OF CHILDREN INTO A STUDY OF PRIMARY CARE TREATMENT OF CHILDHOOD ASTHMA P58
AIRWAY RESPONSIVENESS AND THE CLINICAL DIAGNOSIS OF ASTHMA P59
HOW SEVERE IS ASTHMA IN PATIENTS PRESENTING TO HOSPITAL WITH AN EXACERBATION? P60
THE EFFECT OF ASTHMA NURSE INTERVENTION ON HEALTH OUTCOMES FOLLOWING HOSPITAL ADMISSION P61
EVALUATION OF A HOME BASED COPING SKILLS TRAINING PROGRAMME FOR HIGH RISK ASTHMA SUFFERS P62
ASTHMA NURSE SPECIALIST (ANS) INTERVENTION IN THE MANAGEMENT OF ASTHMA
EVALUATING THE ASTHMA EDUCATION OF WHITE EUROPEAN AND INDIAN SUBCONTINENT ASTHMATICS P64
A COMMUNITY BASED ASSESSMENT OF ASTHMA PREVALENCE, MANAGEMENT STRATEGIES, COMPLIANCE AND TREATMENT PERSPECTIVES AMONGST YOUNG ADULTS IN MELBOURNE, AUSTRALIA P65
THE RELATIONSHIP BETWEEN ASTHMA SYMPTOMS ALONGSIDE ANXIETY AND DEPRESSION P66
ASTHMA MORTALITY IN BIRMINGHAM SOLIHULL AND SHROPSHIRE
SPUTUM INDUCTION TO ASSESS BRONCHIAL INFLAMMATION IN PATIENTS WITH HOMOZYGOUS ALPHA-1-ANTITRYPSIN DEFICIENCY P68
BRONCHIAL INFLAMMATION IN PATIENTS WITH CHRONIC BRONCHITIS, WITH AND WITHOUT ALPHA-1-ANTITRYPSIN DEFICIENCY, AND PATIENTS WITH BRONCHIECTASIS P69
BRONCHODILATOR REVERSIBILITY IN PATIENTS WITH HOMOZYGOUS (PiZ) ALPHA-1-ANTITRYPSIN DEFICIENCY P70
ATTITUDES IN THE DANISH POPULATION AND AFFECTED FAMILIES TOWARDS FAMILY TESTING FOR alpha 1 ANTITRYPSIN DEFICIENCY - A QUESTIONNAIRE STUDY P71
AUTO-CORRELATION LIMITS THE PRECISION OF ESTIMATES OF ANNUAL DECLINE IN FEV1 BASED ON PATIENT ADMINISTERED SERIAL SPIROMETRY (PASS) P72
LUNG FUNCTION AND SURVIVAL IN SUBJECTS WITH alpha1-ANTITRYPSIN DEFICIENCY PiZZ WHO HAVE NEVER SMOKED P73
TESTING FOR alpha1-ANTITRYPSIN (AAT) DEFICIENCY USING DRIED BLOOD SPOTS
EFFECT OF CORTICOSTEROIDS ON PULMONARY beta ADRENERGIC RECEPTOR DENSITY AND FUNCTION P75
A SINGLE HIGH DOSE OF BUDESONIDE RAPIDLY REVERSES EFORMOTEROL INDUCED DESENSITISATION TO BRONCHOPROTECTION AGAINST ADENOSINE MONOPHOSPHATE (AMP) CHALLENGE P76
THE INCREASE IN SUBEPITHELIAL BLOOD VESSELS IN ASTHMATIC AIRWAYS MAY HAVE RELEVANCE TO BHR AND MAY BE STEROID RESPONSIVE P77
Antigen induced hyperreactivity to histamine is vagally mediated. P78
COUGH RESPONSES TO SUBSTANCE P, PGF2alpha AND LOW CHLORIDE IN IDIOPATHIC PERSISTENT COUGH P79
USE OF LEUKOTRIENE C4 FOR DETECTION OF AIRWAY HYPERREACTIVITY IN ASTHMA P80
DIFFERENTIAL REGULATION ON SHORT- AND LONG-TERM PGE2 RELEASE BY BRADYKININ IN HUMAN AIRWAY SMOOTH MUSCLE CELLS
ROLE OF CYCLOOXYGENASE-2 INDUCTION IN IL-1 beta INDUCED DESENSITISATION OF HUMAN AIRWAY SMOOTH MUSCLE CELL RESPONSES TO ISOPRENALINE P82
BRADYKININ INDUCES IL-8 PRODUCTION VIA THE ACTIVATION OF B2 RECEPTORS IN HUMAN AIRWAY SMOOTH MUSCLE CELLS
IMMUNOCYTOCHEMICAL LOCALISATION OF CYCLOOXYGENASE ISOFORMS IN CULTURED HUMAN AIRWAY CELLS P84
Homologous desensitisation of soluble and particulate guanylyl cyclases in cultured human airway smooth muscle. P85
REGULATION OF NITRIC OXIDE RELEASE FROM AIRSPACE EPITHELIAL CELLS. P86
PROTEASE INHIBITORS MODULATE HUMAN AIRWAY SMOOTH MUSCLE CELL PROLIFERATION IN CULTURE P87
EFFECT OF ENDOGENOUS ACTIVATION OF THE RENIN-ANGIOTENSIN SYSTEM BY LOW SALT DIET ON RAT AIRWAY REMODELLING P88
IS THERE A LOCAL RENIN-ANGIOTENSIN SYSTEM IN THE LUNGS? P89
DIFFERENTIAL DISTRIBUTION OF ANGIOTENSIN II RECEPTOR SUBTYPES IN HUMAN FETAL AND ADULT LUNG P90
EXHALED NITRIC OXIDE MEASUREMENTS AND GRAFT DYSFUNCTION IN PULMONARY TRANSPLANTATION P91
INTERLEUKIN-8 IN BRONCHOALVEOLAR LAVAGE FLUID FROM BONE MARROW TRANSPLANT RECIPIENTS P92
NEUTROPHIL MIGRATION ACROSS HUMAN PULMONARY ENDOTHELIAL MONOLAYERS P93
MIGRATION OF NEUTROPHILS THROUGH HUMAN PULMONARY ENDOTHELIAL MONOLAYERS IS NOT INHIBITED BY INHIBITORS OF MATRIX METALLOPROTEINASES P94
INDUCTION OF INTERLEUKIN-8 AND TUMOUR NECROSIS FACTOR ALPHA EXPRESSION IN LUNG EPITHELIAL CELLS FOLLOWING EXPOSURE TO ULTRAFINE PARTICLES AND QUARTZ P95
ULTRAFINE CARBON PARTICLES
INVESTIGATION TO DETERMINE WHETHER THE INFLAMMATORY RESPONSE IN ARDS DEGRADES PULMONARY SURFACTANT SPECIFIC PROTEIN A (SP-A) IN VIVO P97
IS HEME OXYGENASE PRESENT IN PLASMA AND BALF FROM PATIENTS WITH ARDS? P98
HYDROGEN PEROXIDE AND CATALASE ARE INVERSELY RELATED DURING CARDIOPULMONARY BYPASS P99
IRON OVERLOAD DURING PAEDIATRIC CARDIOPULMONARY BYPASS P100
CHARACTERISATION OF gamma-GLUTAMYLCYSTEINE SYNTHETASE GENE PROMOTER
THE COMPARATIVE ABILITY OF THIOL COMPOUNDS TO PROTECT AGAINST HYDROGEN PEROXIDE-INDUCED INJURY IN AIRWAY EPITHELIAL CELLS. P102
LONG-TERM OBSERVATION IN A GROUP OF CHERNOBYL DISASTER LIQUIDATORS TREATED WITH N-ACETYLCYSTEIN P103
SYSTEMIC DOSE RESPONSE RELATIONSHIPS WITH ORAL AND INHALED CORTICOSTEROIDS IN ASTHMATICS P104
CLICKHALER [TM], A NOVEL MULTIDOSE DRY POWDER INHALER HAS HIGH ACCEPTABILITY IN PATIENTS WITH ASTHMA P105
EFFICACY AND SAFETY OF BECLOMETHASONE DIPROPIONATE (BDP) DELIVERED VIA A NOVEL DRY POWDER INHALER (CLICKHALER [TM]) IN PAEDIATRIC PATIENTS WITH ASTHMA. P106
MINIMUM DOSE OF INHALED LACTOSE SENSED BY ASTHMATIC PATIENTS. P107
HFA-BECLOMETHASONE (BDP) EXTRAFINE AEROSOL IMPROVES THERAPEUTIC INDEX P108
RANDOMISED, DOUBLE BLIND, PARALLEL GROUP STUDY COMPARING THE EFFECTS OF FLUTICASONE PROPIONATE (FP) 2000 micro g DAILY WITH PLACEBO OVER 6 WEEKS ON AIRWAY RESPONSIVENESS IN STEROID NAIVE SUBJECTS P109
COMPARISON OF BTS AND AMERICAN TREATMENT REGIMENS FOR THE TREATMENT OF INPATIENTS WITH ACUTE ASTHMA P110
BAMBUTEROL VERSUS SALMETEROL IN ASTHMA PATIENTS WITH NOCTURNAL SYMPTOMS P111
WHAT DO PROPHYLACTIC TO BRONCHODILATOR RATIOS MEAN? P112
LOCAL RESEARCH ETHICS COMMITTEES AND A RANDOMISED CONTROLLED TRIAL OF REGULAR VERSUS AS NEEDED SALBUTAMOL IN MILD TO MODERATE ASTHMA
THE EFFECT OF PERINATAL EXPOSURE TO CHRONIC HYPOXIA, L-NAME AND INDOMETHACIN UPON VASCULAR REACTIVITY AND VESSEL COMPLIANCE IN THE RAT P114
ADVERSE PERINATAL INTERVENTION AND INDICES OF PULMONARY HYPERTENSION IN ADULT RAT P115
ALTERED BREATHING PATTERN IN THE FAWN HOODED RAT
THE EFFECT OF CHRONIC DEXFENFLURAMINE ON PLATELET FUNCTION IN THE WISTAR AND THE FAWN-HOODED RAT P117
THE EFFECT OF DEXFENFLURAMINE ON 5-HYDROXYTRYPTAMINE CLEARANCE IN THE PORCINE LUNG P118
ENHANCED PULMONARY VASOREACTIVITY TO SEROTONIN IN THE FAWN HOODED RAT P119
THE PULMONARY HYPERTENSIVE FAWN-HOODED RAT HAS A NORMAL SEROTONIN TRANSPORTER CODING SEQUENCE P120
OXIDANT STRESS INDUCES THE RELEASE OF BOTH PGE2 AND 8-ISO PGF2 alpha BY A COX-2 DEPENDENT PATHWAY. P121
CO-INDUCTION OF iNOS AND COX-2 IN P.A. SMOOTH MUSCLE CELLS
DIETARY FLAVANOIDS CAUSE RELAXATION OF RAT PULMONARY ARTERIES P123
ANGIOTENSIN CONVERTING ENZYME EXPRESSION IN CHILDREN AND ADULTS WITH PULMONARY HYPERTENSION P124
LOCALISATION OF ANGIOTENSIN II RECEPTOR SUBTYPES IN HUMAN PULMONARY ARTERY AND AT1 MEDIATED SMOOTH MUSCLE CELL GROWTH RESPONSES IN VITRO P125
EFFECT OF ENDOTHELIN ON PROTEIN SYNTHESIS IN SMOOTH MUSCLE CELLS FROM RAT PULMONARY MICROVASCULATURE P126
EVIDENCE FOR TWO ENDOTHELINB RECEPTORS ON RABBIT PULMONARY RESISTANCE ARTERIES. P127
THE EFFECT OF THE ENDOTHELIN-1 RECEPTOR ANTAGONIST PD156707 IN RATS WITH ESTABLISHED HYPOXIC PULMONARY HYPERTENSION P128
PLASMA LEVELS OF BIG ENDOTHELIN-1 AND ENDOTHELIN-1 IN NEONATES WITH PULMONARY HYPERTENSION REFERRED FOR POTENTIAL EXTRA CORPOREAL MEMBRANE OXYGENATION SUPPORT P129
Cardiopulmonary exercise testing assessment of the efficacy of oral vasodilators in patients with pulmonary hypertension secondary to connective tissue disease. P130
CLEARANCE OF INHALED99m Tc-DTPA AS A CLINICAL INDEX OF PURE PULMONARY VASCULAR DISEASE IN SYSTEMIC SCLEROSIS P131
GENETIC PREDISPOSITION TO SCLERODERMA P132
TNF-alpha AND LYMPHOTOXIN-alpha POLYMORPHISMS IN SARCOIDOSIS - NO ASSOCIATION P133
HRCT DIAGNOSED LUNG DISEASE IN PATIENTS WITH RHEUMATOID ARTHRITIS P134
CLINICAL, PHYSIOLOGICAL AND RADIOLOGICAL CHARACTERISTICS OF PULMONARY DISEASE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE P135
PREGNANCY IN LYMPHANGIOLEIOMYOMATOSIS P136
LUNG FUNCTION IMPAIRMENT DOES NOT FOLLOW VIDEO ASSISTED THORACOSCOPIC LUNG BIOPSY FOR THE DIAGNOSIS OF INTERSTITIAL LUNG DISEASE P137
ROLE OF BRONCHOSCOPY IN AN INDIAN CRITICAL CARE UNIT AN EXPERIENCE OF 118 PROCEDURES P138
UNDERWATER PHOTOGRAPHY IN THE HUMAN AIRWAY, THE USE OF SALINE TO VISUALISE PERIPHERAL TUMOURS AND EVALUATE AIRWAY RIGIDITY P139
TITLE
DOES OXYGEN DESATURATION OCCUR DURING BRONCHOSCOPY IN PATIENTS RECEIVING SUPPLEMENTAL OXYGEN? P141
FLUTTER VALVE DRAINAGE BAGS ARE MORE EFFECTIVE THAN UNDERWATER SEAL SYSTEMS IN POSTOPERATIVE AIR LEAKS P142
COMPARATIVE TRIAL OF TRU-CUT BIOPSY NEEDLE VS ABRAMS PUNCH FOR PLEURAL BIOPSY P143
INTRAPLEURAL STREPTOKINASE IN THE DRAINAGE OF MALIGNANT MULTILOCULATED PLEURAL EFFUSIONS P144
HAEMODYNAMIC EFFECTS OF INCREASING INSPIRED OXYGEN CONCENTRATION P145
METABOLIC RATE AND INFLAMMATORY MARKERS IN COPD AND BRONCHIECTASIS P146
INSPIRATORY FLOW RATE GENERATION THROUGH THE ACTIVHALER IN ELDERLY PATIENTS WITH OBSTRUCTIVE AIRWAYS DISEASE P147
WHO SHOULD PAY AND WHO DOES PAY FOR NEBULISER COMPRESSORS? P148
Preliminary Results Of The Influence Of Guidelines On The Management Of Acute Exacerbations Of Chronic Obstructive Pulmonary Disease P149
THE PROVISION OF NON-INVASIVE VENTILATION(NIPPV) FOR ACUTE EXACERBATIONS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN THE UNITED KINGDOM P150
GUIDELINES AND FUNDING FOR THE USE OF RECOMBINANT DNASE IN ONE REGIONAL ADULT CYSTIC FIBROSIS UNIT P151
DISABILITY LIVING ALLOWANCE, MOBILITY ALLOWANCE AND ATTENDANCE ALLOWANCE IN ADULTS WITH CYSTIC FIBROSIS IN THE UNITED KINGDOM P152
WHAT DO ADULTS WITH CF LIKE AND DISLIKE ABOUT THE MEDICAL CARE THEY RECEIVE IN THE UNITED KINGDOM? P153
ACCESS TO SPECIALIST CARE FOR ADULTS WITH CF IN THE UNITED KINGDOM P154
AUDIT OF ACUTE ASTHMA ATTACKS P155
ACCIDENT AND EMERGENCY DEPARTMENT - A PRIMARY CARE FACILITY FOR RESPIRATORY ILLNESS? P156
CARE OF THE ASTHMATIC BEGINS IN THE AMBULANCE P157
IMPROVED DOCUMENTATION FOR THE ASSESSMENT OF ACUTE ASTHMA IN AN A & E DEPARTMENT. P158
THE OPINIONS OF SOME HEALTHCARE PROFESSIONALS ON THE TRAINING OF INHALATION TECHNIQUE P159
RELATIONSHIPS BETWEEN PULMONARY FUNCTION AND THE TIMED SWALLOW TEST
HYPERVENTILATION SYNDROME
COMPARISON OF STANDARDISED RESIDUALS AND PERCENT PREDICTED IN DELINEATING NORMAL FROM ABNORMAL LUNG FUNCTION TEST RESULTS P162
ASSESSING PEAK FLOW CHARTS
Home Investigation of Suspected Obstructive Sleep Apnoea (OSAS) in 103 Patients. P164
DIAGNOSTIC COMPARISON OF HOME VERSUS HOSPITAL-BASED INVESTIGATION OF OBSTRUCTIVE SLEEP APNOEA (OSA) P165
COST COMPARISON OF HOME VERSUS HOSPITAL-BASED INVESTIGATION OF OBSTRUCTIVE SLEEP APNOEA (OSA) P166
EXPIRED AIR CARBON MONOXIDE LEVELS AND SMOKING HISTORIES IN PATIENTS NEWLY REFERRED TO GENERAL AND OCCUPATIONAL CHEST CLINICS P167
CYP2D6 POLYMORPHISM AND THE ANTI-TUSSIVE EFFECT OF DEXTROMETHORPHAN IN MAN P168
JOINT HYPERMOBILITY IN PATIENTS WITH PRIMARY SPONTANEOUS PNEUMOTHORAX.(PSP) P169
Long term survival after hospital discharge from A Progressive Care Programme (PCP) for patients failing to wean from invasive ventilation on ICU P170
COUGH FUNCTION IN MOTOR NEURONE DISEASE P171
RECOVERY OF STRENGTH IN BILATERAL DIAPHRAGM PARALYSIS DUE TO NEURALGIC AMYOTROPHY P172
OCCUPATIONAL ASTHMA DUE TO TRIGLYCIDYL ISOCYANURATE (TGIC) P173
AMIODARONE & THE LUNG
GENERAL PRACTICE SPIROMETRY IN NORTH STAFFORDSHIRE P175
LUNG FUNCTION CHARACTERISTICS OF ELDERLY PEOPLE WITH A DIAGNOSTIC LABEL OF ASTHMA P176
RESPIRATORY SYMPTOMS DO NOT PREDICT AIRWAYS OBSTRUCTION IN AN ELDERLY HOSPITAL POPULATION P177
MOST PATIENTS WITH STABLE COPD PREFER INHALED TO NEBULISED BRONCHODILATORS P178
CLINICAL AND PHYSIOLOGICAL CHARACTERISTICS OF COPD PATIENTS RESPONDING TO DOMICILIARY NEBULISED BRONCHODILATOR P179
INFLUENCE OF ORDER OF ADMINISTRATION ON RESPONSE TO NEBULISED IPRATROPIUM BROMIDE AND SALBUTAMOL P180
CONTAMINATION OF NEBULIZER CHAMBERS IN DOMICILIARY USE P181
THE IMPACT OF OUTREACH RESPIRATORY NURSE SPECIALIST SERVICE ON SECONDARY CARE IN COPD P182
HOW WELL ARE RECOMMENDATIONS ON IMMUNISATION IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE(COPD) BEING MET IN EAST YORKSHIRE P183
SMOKING CESSATION COUNSELLOR - BENEFIT AND COST P184
HAND HELD NOTES FOR PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE [COPD] P185
THE PERCEPTIONS AND NEEDS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE PATIENTS P186
PALLIATIVE CARE AND ANXIETY AND DEPRESSION IN END-STAGE CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
USE OF TIDAL BREATHING EXPIRATORY FLOW PROFILES TO ASSESS AIRFLOW OBSTRUCTION P188
Diagnosis of airflow obstruction from analysis of tidal breathing P189
BRONCHODILATOR EFFECTS ON BREATH SOUND FREQUENCY IN ASTHMA P190
AIRWAY RESISTANCE MEASUREMENTS
IMPULSE OSCILLOMETRY
MONITORING PULMONARY OEDEMA BY ELECTRICAL IMPEDANCE TOMOGRAPHY P193
INSPIRATORY MUSCLE ENDURANCE AND LUNG VOLUMES IN CHRONIC STABLE HEART FAILURE P194
INSPIRATORY MUSCLE ENDURANCE IN ADULTS WITH MILD-MODERATE IDIOPATHIC SCOLIOSIS P195
DOES OBSTRUCTIVE SLEEP APNOEA HAVE A TRAINING EFFECT ON THE INSPIRATORY MUSCLES? P196
INSPIRATORY MUSCLE STRENGTH IN ACUTE ASTHMA MEASURED BY SNIFF NASAL PRESSURE (SNIP) P197
MEASURING PHRENIC NERVE CONDUCTION TIME WITH MAGNETIC STIMULATION P198
COUGH SIMULATED BY RAPID RATE MAGNETIC STIMULATION OF THE THORACIC NERVE ROOTS P199
GRAVITATIONAL GRADIENT OF PERFUSION PERSISTS IN THE PRONE POSITION IN VENTILATED NORMAL SUBJECTS P200
COMPARISON OF THE LUNG DEPOSITION OF RADIOLABELLED BECLOMETHASONE DIPROPIONATE (BDP) FROM A NOVEL DRY POWDER INHALER (DPI), CONVENTIONAL PRESSURISED METERED DOSE INHALER (MDI) AND MDI WITH A SPACER ATTACHMENT P201
REDUCED NEED FOR A SPACER ATTACHMENT WITH EXTRAFINE AEROSOL MDI P202
SPRAY FORCE AND TEMPERATURE OF CFC AND HFA-134a PROPELLANT AEROSOL MDIs P203
FURTHER VALIDATION ON THE USE OF URINARY SALBUTAMOL EXCRETION TO EVALUATE THE RELATIVE BIOAVAILABILITY OF SALBUTAMOL TO THE LUNG FOLLOWING INHALATION P204
THE RELATIVE LUNG BIOAVAILABILITY OF SALBUTAMOL FOLLOWING ADMINISTRATION BY METERED DOSE INHALER AND NEBULISER P205
THE OUTPUT OF SALBUTAMOL FROM NEBULISERS AT DIFFERENT BREATHING PATTERNS P206
ESTIMATES OF THE DOSAGES OF SALBUTAMOL SULPHATE DELIVERED TO THE RESPIRATORY TRACT FROM THREE NEBULIZERS P207
HALOLITE[TM] A NOVEL LIQUID DRUG AEROSOL DELIVERY SYSTEM P208
ASSESSMENT OF THE BARRIERS TO CATIONIC LIPOSOME-MEDIATED PULMONARY GENE TRANSFER P209
SELECTION OF NOVEL CATIONIC LIPOSOMES FOR RESPIRATORY GENE THERAPY P210
EFFECTS OF INFLUENZA VIRUS ON GENE TRANSFER IN VIVO P211
alpha1-ANTITRYPSIN DEFICIENCY IN SEVERE CYSTIC FIBROSIS (CF) LUNG DISEASE P212
NITRITE LEVELS IN BREATH CONDENSATE OF CF PATIENTS ARE RAISED IN CONTRAST TO EXHALED NITRIC OXIDE (NO) LEVELS P213
PULMONARY FUNCTION, INFLAMMATORY MARKERS AND BURKHOLDERIA CEPACIA ANTIBODIES IN CYSTIC FIBROSIS ADULTS PRECEEDING AND FOLLOWING PULMONARY COLONISATION WITH BURKHOLDERIA CEPACIA P214
INTERLEUKIN-10 PROMOTER GENOTYPE IN RELATION TO PULMONARY FUNCTION, BMI AND BACTERIAL COLONISATION IN CYSTIC FIBROSIS P215
A COMPARISON OF DELAYED HYPER-SENSITIVITY (DHT) IN ADULT CYSTIC FIBROSIS WITH SARCOIDOSIS AND HIV INFECTED PATIENTS P216
Beta-cell Dysfunction and Insulin Resistance in Adult Patients with Cystic Fibrosis P217
Acknowledgment